Literature DB >> 20545785

Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells.

Julie M Davies1, John MacSharry, Fergus Shanahan.   

Abstract

Toll-like receptor (TLR) signalling shapes dendritic cell (DC) responses by inducing co-stimulatory molecule up-regulation and cytokine secretion while TLR regulatory proteins inhibit this process. We aimed to determine if gene expression of TLRs and TLR regulatory proteins underpins the functionally different lipopolysaccharide (LPS) responses of DCs from murine Peyer's patches (PP) and spleen and of murine bacteria-conditioned bone-marrow-derived cells. Isolated spleen and PP DCs were analysed for basal expression of TLRs by flow cytometry and real time quantitative reverse transcription polymerase chain reaction (qRT-PCR). The DCs were stimulated with LPS to determine cytokine secretion by enzyme-linked immunosorbent assay and expression of TLR regulatory proteins by qRT-PCR. In vitro results were confirmed following in vivo intraperitoneal LPS injection. In addition, changes in gene expression of TLR regulatory proteins were assessed in bacteria-conditioned bone-marrow-derived cells. Results indicated that surface expression of TLR2 and TLR4 on PP DCs was decreased compared with spleen DCs. The PP DCs secreted a limited profile of cytokines compared with spleen DCs following LPS stimulation. In vivo LPS exposure up-regulated sigirr, tollip and tmed1 messenger RNA in PP DCs, but not spleen DCs. Similar gene expression changes were observed in bacteria-conditioned bone-marrow-derived cells. Therefore, functionally different LPS responses in PP and spleen DCs reflect their characteristic expression of TLRs and TLR regulatory proteins. Differential regulation of TLR signalling was also evident in bacteria-conditioned bone-marrow-derived cells indicating that bacterial signalling may be a mechanism for inducing altered gene regulation in PP DCs.
© 2010 The Authors. Immunology © 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20545785      PMCID: PMC2996564          DOI: 10.1111/j.1365-2567.2010.03317.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  38 in total

1.  Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.

Authors:  K Burns; J Clatworthy; L Martin; F Martinon; C Plumpton; B Maschera; A Lewis; K Ray; J Tschopp; F Volpe
Journal:  Nat Cell Biol       Date:  2000-06       Impact factor: 28.824

2.  IRAK-M is a negative regulator of Toll-like receptor signaling.

Authors:  Koichi Kobayashi; Lorraine D Hernandez; Jorge E Galán; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Cell       Date:  2002-07-26       Impact factor: 41.582

3.  SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.

Authors:  Kevin Evel-Kabler; Xiao-Tong Song; Melissa Aldrich; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

4.  Negative regulation of toll-like receptor-mediated signaling by Tollip.

Authors:  Guolong Zhang; Sankar Ghosh
Journal:  J Biol Chem       Date:  2001-12-18       Impact factor: 5.157

5.  Bacterial signalling overrides cytokine signalling and modifies dendritic cell differentiation.

Authors:  Julie M Davies; Barbara Sheil; Fergus Shanahan
Journal:  Immunology       Date:  2009-03-23       Impact factor: 7.397

6.  Low responsiveness to IFN-gamma, after pretreatment of mouse macrophages with lipopolysaccharides, develops via diverse regulatory pathways.

Authors:  Ana Crespo; Michael B Filla; William J Murphy
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

7.  The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo.

Authors:  J G Zhang; D Metcalf; S Rakar; M Asimakis; C J Greenhalgh; T A Willson; R Starr; S E Nicholson; W Carter; W S Alexander; D J Hilton; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

8.  Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family.

Authors:  Cecilia Garlanda; Federica Riva; Tania Veliz; Nadia Polentarutti; Fabio Pasqualini; Enrico Radaelli; Marina Sironi; Manuela Nebuloni; Elisabetta Omodeo Zorini; Eugenio Scanziani; Alberto Mantovani
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

9.  Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved.

Authors:  Takatoshi Chinen; Takashi Kobayashi; Hisanobu Ogata; Giichi Takaesu; Hiromi Takaki; Masayuki Hashimoto; Hideo Yagita; Hajime Nawata; Akihiko Yoshimura
Journal:  Gastroenterology       Date:  2006-02       Impact factor: 22.682

10.  Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells.

Authors:  A Iwasaki; B L Kelsall
Journal:  J Exp Med       Date:  1999-07-19       Impact factor: 14.307

View more
  13 in total

1.  Tissue-specific mRNA expression profiles of porcine Toll-like receptors at different ages in germ-free and conventional pigs.

Authors:  Lulu Shao; David D Fischer; Sukumar Kandasamy; Linda J Saif; Anastasia N Vlasova
Journal:  Vet Immunol Immunopathol       Date:  2016-02-01       Impact factor: 2.046

2.  Secretory IgA in complex with Lactobacillus rhamnosus potentiates mucosal dendritic cell-mediated Treg cell differentiation via TLR regulatory proteins, RALDH2 and secretion of IL-10 and TGF-β.

Authors:  Josip Mikulic; Stéphanie Longet; Laurent Favre; Jalil Benyacoub; Blaise Corthesy
Journal:  Cell Mol Immunol       Date:  2016-03-14       Impact factor: 11.530

3.  Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils.

Authors:  Keiko Ueno-Shuto; Kosuke Kato; Yukihiro Tasaki; Miki Sato; Keizo Sato; Yuji Uchida; Hiromichi Sakai; Tomomi Ono; Mary Ann Suico; Kazunori Mitsutake; Naofumi Tokutomi; Hirofumi Kai; Tsuyoshi Shuto
Journal:  J Biol Chem       Date:  2014-05-12       Impact factor: 5.157

4.  Inhibitory feedback control of NF-κB signalling in health and disease.

Authors:  Jack A Prescott; Jennifer P Mitchell; Simon J Cook
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

5.  An endogenous nanomineral chaperones luminal antigen and peptidoglycan to intestinal immune cells.

Authors:  Jonathan J Powell; Emma Thomas-McKay; Vinay Thoree; Jack Robertson; Rachel E Hewitt; Jeremy N Skepper; Andy Brown; Juan Carlos Hernandez-Garrido; Paul A Midgley; Inmaculada Gomez-Morilla; Geoffrey W Grime; Karen J Kirkby; Neil A Mabbott; David S Donaldson; Ifor R Williams; Daniel Rios; Stephen E Girardin; Carolin T Haas; Sylvaine F A Bruggraber; Jon D Laman; Yakup Tanriver; Giovanna Lombardi; Robert Lechler; Richard P H Thompson; Laetitia C Pele
Journal:  Nat Nanotechnol       Date:  2015-03-09       Impact factor: 39.213

6.  TIR8/SIGIRR is an Interleukin-1 Receptor/Toll Like Receptor Family Member with Regulatory Functions in Inflammation and Immunity.

Authors:  Federica Riva; Eduardo Bonavita; Elisa Barbati; Marta Muzio; Alberto Mantovani; Cecilia Garlanda
Journal:  Front Immunol       Date:  2012-10-29       Impact factor: 7.561

7.  Enhancement of inflammatory protein expression and nuclear factor Κb (NF-Κb) activity by trichostatin A (TSA) in OP9 preadipocytes.

Authors:  Taiki Sato; Daisuke Kotake; Masahiro Hiratsuka; Noriyasu Hirasawa
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

8.  Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily.

Authors:  Cecilia Garlanda; Federica Riva; Eduardo Bonavita; Stefania Gentile; Alberto Mantovani
Journal:  Front Immunol       Date:  2013-07-09       Impact factor: 7.561

9.  Role of toll-like receptor 4 on lupus lung injury and atherosclerosis in LPS-challenge ApoE⁻/⁻ mice.

Authors:  Jing-qin Ni; Qiufang Ouyang; Ling Lin; Ziyang Huang; Huixia Lu; Xiaoqing Chen; Huili Lin; Zhenhua Wang; Dongming Xu; Yun Zhang
Journal:  Clin Dev Immunol       Date:  2013-09-15

Review 10.  Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.

Authors:  Martina Molgora; Domenico Supino; Alberto Mantovani; Cecilia Garlanda
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.